Aging blocks the retina's ability to regrow lost neurons, a first-of-its-kind study finds
A new study from the laboratory of Levi Todd, Ph.D., at Upstate Medical University has found that aging significantly limits the ability of support cells in the retina, called glia, to be reprogrammed into new neurons, a finding with important implications for the future of regenerative medicine for age-related neurodegenerative diseases such as Alzheimer's, Parkinson's and glaucoma.
A recent study led by Levi Todd at Upstate Medical University reveals that aging significantly hinders the retina's capacity to regenerate lost neurons. Published in the Proceedings of the National Academy of Sciences, this pioneering research underscores the crucial role of glial cells, which support neurons throughout the brain and retina, in age-related neurodegenerative diseases such as Alzheimer's, Parkinson's, and glaucoma.
The lab's investigation demonstrates that while glial reprogramming has proven successful in young animals, its efficacy is notably diminished in aged tissue. This finding holds immense importance given the predominance of neurodegenerative diseases linked to aging. Glial cells, which nurture and nourish neurons, can naturally revert to a stem-cell-like state to generate replacements in certain animals, including zebrafish and frogs.
However, this process has only recently been observed in young mice retinas. The broader field of glial reprogramming has expanded rapidly since the initial discovery in 2017, yet most advancements have been focused on refining techniques in younger animals. Todd emphasizes that while there is still hope for regenerating the aged nervous system, the challenges are significantly greater.
His team identified two primary factors contributing to the reduced efficiency of glial-to-neuron reprogramming with age. Firstly, the inherited cells from birth, such as neurons and glia, can become "tired" and lose plasticity over time. Secondly, inflammaging—an age-related increase in inflammation—plays a pivotal role. As inflammation escalates with age, it exacerbates the difficulty of regeneration.
The blood-brain barrier, which typically keeps the immune system at bay in the brain, weakens with age, further complicating the regeneration process. However, the research also presents a potential solution. By dampening the immune system with anti-inflammatory steroids, the team observed a partial restoration of the retina's regenerative response in aged neurons.
The laboratory plans to delve deeper into pinpointing specific molecules and pathways that impede regeneration, aiming to develop more precise therapies. Future research will focus on identifying the exact mechanisms of inflammation that hinder regeneration and exploring targeted interventions to enhance regenerative capabilities without broad immunosuppression.
Todd acknowledges the crucial role of the graduate students who led the study, praising their contributions and highlighting the importance of mentoring in scientific progress.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
